| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2023 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CME GROUP INC | 42 | Q3 2023 | 0.2% |
| CITIGROUP INC | 40 | Q3 2023 | 5.1% |
| CITIGROUP INC | 40 | Q3 2023 | 3.9% |
| MORGAN STANLEY | 39 | Q3 2023 | 1.3% |
| APPLE INC | 38 | Q3 2023 | 6.4% |
| JPMORGAN CHASE & CO | 38 | Q3 2023 | 3.6% |
| BK OF AMERICA CORP | 38 | Q3 2023 | 2.1% |
| JPMORGAN CHASE & CO | 38 | Q3 2023 | 2.3% |
| APPLE INC | 37 | Q3 2023 | 6.2% |
| BK OF AMERICA CORP | 37 | Q3 2023 | 2.2% |
View Laurion Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Codiak BioSciences, Inc. | March 03, 2023 | 3,713,300 | 9.6% |
| Pyxis Oncology, Inc. | February 08, 2023 | 3,170,803 | 9.0% |
| Research Alliance Corp. II | February 08, 2023 | ? | ? |
View Laurion Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G | 2024-02-08 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-03-03 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-08 |
View Laurion Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.